BioRestorative Therapies Inc [NASDAQ: BRTX] price surged by 0.60 percent to reach at $0.01.
A sum of 175130 shares traded at recent session while its average daily volume was at 140.71K shares. BioRestorative Therapies Inc shares reached a high of $1.8888 and dropped to a low of $1.7559 until finishing in the latest session at $1.84.
The one-year BRTX stock forecast points to a potential upside of 85.85. The average equity rating for BRTX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on BioRestorative Therapies Inc [BRTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BRTX shares is $13.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BRTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 3.04, with the Price to Cash per share for the same quarter was set at 0.93.
BRTX Stock Performance Analysis:
BioRestorative Therapies Inc [BRTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.26. With this latest performance, BRTX shares gained by 25.17% in over the last four-week period, additionally plugging by 21.05% over the last 6 months – not to mention a rise of 28.67% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BRTX stock in for the last two-week period is set at 72.77, with the RSI for the last a single of trading hit 0.0949, and the three-weeks RSI is set at 0.0915 for BioRestorative Therapies Inc [BRTX]. The present Moving Average for the last 50 days of trading for this stock 1.5697, while it was recorded at 1.6526 for the last single week of trading, and 1.7085 for the last 200 days.
Insight into BioRestorative Therapies Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and BioRestorative Therapies Inc [BRTX] shares currently have an operating margin of -2162.91% and a Gross Margin at 60.94%. BioRestorative Therapies Inc’s Net Margin is presently recorded at -1771.91%.
BioRestorative Therapies Inc (BRTX) Capital Structure & Debt Analysis
According to recent financial data for BioRestorative Therapies Inc. ( BRTX), the Return on Equity (ROE) stands at -137.09%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -87.06%, reflecting the company’s efficiency in generating profits from its assets. Additionally, BioRestorative Therapies Inc’s Return on Invested Capital (ROIC) is -221.32%, showcasing its effectiveness in deploying capital for earnings.
BioRestorative Therapies Inc (BRTX) Efficiency & Liquidity Metrics
Based on BioRestorative Therapies Inc’s (BRTX) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
BioRestorative Therapies Inc (BRTX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, BioRestorative Therapies Inc. (BRTX) effectively leverages its workforce, generating an average of -$974545.45 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.06% and a Quick Ratio of 2.06%, indicating strong ability to cover short-term liabilities.
BRTX Stock EPS
With the latest financial reports released by the company, BioRestorative Therapies Inc posted -0.01/share EPS, while the average EPS was predicted by analysts to be reported at -0.35/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.34. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BRTX.
BioRestorative Therapies Inc [BRTX] Institutonal Ownership Details
There are presently around $8.77%, or 11.54%% of BRTX stock, in the hands of institutional investors. The top three institutional holders of BRTX stocks are: GEODE CAPITAL MANAGEMENT, LLC with ownership of 52337.0 shares, which is approximately 0.7845%. STONEX GROUP INC., holding 56921.0 shares of the stock with an approximate value of $$0.12 million in BRTX stocks shares; and STONEX GROUP INC., currently with $$81200.0 in BRTX stock with ownership which is approximately 0.5996%.
